A Prospective Study Comparing Paroxetine Alone Versus Paroxetine Plus Sildenafil in Patients With Premature Ejaculation

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Dec 2002A Prospective Study Comparing Paroxetine Alone Versus Paroxetine Plus Sildenafil in Patients With Premature Ejaculation ANDREA SALONIA, TOMMASO MAGA, RENZO COLOMBO, VINCENZO SCATTONI, ALBERTO BRIGANTI, ANDREA CESTARI, GIORGIO GUAZZONI, PATRIZIO RIGATTI, and FRANCESCO MONTORSI ANDREA SALONIAANDREA SALONIA, TOMMASO MAGATOMMASO MAGA, RENZO COLOMBORENZO COLOMBO, VINCENZO SCATTONIVINCENZO SCATTONI, ALBERTO BRIGANTIALBERTO BRIGANTI, ANDREA CESTARIANDREA CESTARI, GIORGIO GUAZZONIGIORGIO GUAZZONI, PATRIZIO RIGATTIPATRIZIO RIGATTI, and FRANCESCO MONTORSIFRANCESCO MONTORSI View All Author Informationhttps: //doi. org/10. 1016/S0022-5347 (05) 64174-2AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We compared the efficacy of paroxetine alone and combined with sildenafil in patients complaining of premature ejaculation. Materials and Methods: Enrolled in this study were 80 consecutive potent men 19 to 47 years old (mean age 34) with premature ejaculation but without any obvious organic cause. Pretreatment evaluation included a history, self-administration of the International Index of Erectile Function (IIEF) questionnaire, physical examination and the Meares-Stamey test to exclude genital tract infection. The initial 40 patients received 10 mg. paroxetine daily for 21 days and then 20 mg. as needed, that is 3 to 4 hours before planned sexual activity, for 6 months (group 1). The other group of 40 men received 10 mg. paroxetine daily for 21 days and then 20 mg. as needed plus 50 mg. sildenafil as needed, that is 1 hour before planned sexual activity, for 6 months (group 2). Patients were followed 3 and 6 months after beginning therapy and were evaluated using several general assessment questions, IIEF and ejaculatory latency time. Results: Mean ejaculatory latency time ± SE in group 1 was 0. 33 ± 0. 04, 3. 7 ± 0. 10 (p <0. 01) and 4. 2 ± 0. 03 (p <0. 01) minutes at baseline, 3 and 6-month followup, while in group 2 it was 0. 35 ± 0. 03, 4. 5 ± 0. 07 (p <0. 01) and 5. 3 ± 0. 02 (p <0. 001) minutes, respectively. When improvement in ejaculatory latency time was compared in the 2 groups, group 2 results proved to be significantly greater (p <0. 05). Baseline, and 3 and 6-month mean intercourse satisfaction domain values of the IIEF were 9, 11 and 11 (p = 0. 09, not significant), and 9, 11 and 14 (p <0. 05) in groups 1 and 2, respectively. Group 2 patients reported significantly greater intercourse satisfaction than those in group 1 (p <0. 05). At baseline, 3 and 6 months there was a mean of 0. 9 ± 0. 1, 1. 7 ± 0. 3 (not significant) and 2. 5 ± 0. 3 (p <0. 01) coitus episodes weekly in group 1, and 1 ± 0. 2, 2. 3 ± 0. 3 (p <0. 01) and 3. 2 ± 0. 1 (p <0. 001) in group 2, respectively. Group 2 patients reported a significantly higher number of coitus episodes weekly (p <0. 05). Side effects in the 40 group 1 cases included anejaculation in 1 (2. 5%), gastrointestinal upset and/or nausea in 5 (12. 5%), headache in 4 (10%) and decreased libido in 2 (5%). Side effects in the 40 group 2 cases included anejaculation in 1 (2. 5%), headache in 8 (20%), gastrointestinal upset and/or nausea in 6 (15%) and flushing in 6 (15%). Group 2 patients reported significantly more headaches (p <0. 01) and flushing episodes (p <0. 001) than those in group 1. After 6 months of treatment 33 men (82. 5%) in group 1 and 36 (90%) in group 2 were willing to continue therapy (not significant). Conclusions: Paroxetine combined with sildenafil appears to provide significantly better results in terms of ejaculatory latency time and intercourse satisfaction versus paroxetine alone in potent patients with premature ejaculation. However, combined treatment is associated with a mild increase in drug related side effects. References 1: Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med1997; 19: 387. Crossref, Medline, Google Scholar 2: Sexual dysfunction in the United States: prevalence and predictors. JAMA1999; 281: 537. Crossref, Medline, Google Scholar 3 Diagnostic and Statistical Manual of Mental Disorders, DSM-IV. Washington, D. C.: American Psychiatric Association1994: 509. Google Scholar 4: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol1999; 161: 1826. Link, Google Scholar 5: Ejaculatory dysfunction. BJU Int1999; 83: 557. Crossref, Medline, Google Scholar 6: Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol1999; 19: 67. Crossref, Medline, Google Scholar 7: Treatment-emergent sexual dysfunction in affective disorder: a review and management strategies. J Clin Psychiatr Monogr1993; 11: 57. Google Scholar 8: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol1996; 156: 1631. Link, Google Scholar 9: Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol1998; 159: 1935. Link, Google Scholar 10: Paroxetine in the treatment of premature ejaculation. Br J Urol1996; 77: 881. Crossref, Medline, Google Scholar 11: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med1998; 338: 1397. Crossref, Medline, Google Scholar 12: Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol2000; 164: 1192. Link, Google Scholar 13: Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res2001; 13: 41. Crossref, Medline, Google Scholar 14: The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997; 49: 822. Crossref, Medline, Google Scholar 15: Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology1999; 54: 346. Crossref, Medline, Google Scholar 16: Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol1997; 79: 592. Crossref, Medline, Google Scholar 17: A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand1991; 80: 60. Crossref, Google Scholar 18: The roles of nitric oxide in sexual function of male rats. Neuropharmacology1994; 33: 1499. Crossref, Medline, Google Scholar 19: Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS−/−). Physiol Behav1999; 67: 561. Crossref, Medline, Google Scholar 20: Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro. Urology2002; 59: 958. Crossref, Medline, Google Scholar 21: A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction, incidence, possible aetiology and implications for management. J Psychopharmacol1997; 11: 72. Crossref, Medline, Google Scholar 22: The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. Br J Clin Pharmacol1992; 33: 521. Crossref, Medline, Google Scholar 23: Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol2001; 51: 239. Crossref, Medline, Google Scholar From the Department of Urology, University "Vita-Salute" School of Medicine, Scientific Institute H. San Raffaele, Milan, Italy© 2002 by American Urological Association, Inc. FiguresReferencesRelatedDetailsCited by Abdel-Hamid I, Abo-Aly M and Mostafa T (2023) Phosphodiesterase type 5 inhibitors and premature ejaculation: an overview of systematic reviews/meta-analyses using the AMSTAR 2, ROBIS, and GRADE toolsSexual Medicine Reviews, 10. 1093/sxmrev/qeac003, VOL. 11, NO. 1, (23-51), Online publication date: 19-Jan-2023. Mitsogiannis I, Dellis A, Papatsoris A and Moussa M (2022) An up-to-date overview of the pharmacotherapeutic options for premature ejaculationExpert Opinion on Pharmacotherapy, 10. 1080/14656566. 2022. 2035361, VOL. 23, NO. 9, (1043-1050), Online publication date: 13-Jun-2022. Zhou Z, Yang Z, Cui Y, Zhang X, Wang Y and Zhang Y (2022) The network meta‐analysis of "on‐demand" and "daily" use of paroxetine in treating men with premature ejaculation from randomized controlled trialsAndrologia, 10. 1111/and. 14388, VOL. 54, NO. 5, Online publication date: 1-Jun-2022. Mohamed Gharib T, Abdel-Al I, Elatreisy A, Kandeel W, El-Shaer W, Abdrabuh A, Mohamed Salih E and Sebaey A (2022) Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculationArab Journal of Urology, 10. 1080/2090598X. 2021. 2024695, VOL. 20, NO. 1, (49-53), Online publication date: 2-Jan-2022. Saleh R, Majzoub A and Abu El-Hamd M (2021) An update on the treatment of premature ejaculation: A systematic reviewArab Journal of Urology, 10. 1080/2090598X. 2021. 1943273, VOL. 19, NO. 3, (281-302), Online publication date: 3-Jul-2021. Raheem O, Adnan M and Alzweri L (2021) Surgical and Nonsurgical Sperm Retrieval Techniques in Patients with Ejaculatory Dysfunctions Manual of Sperm Retrieval and Preparation in Human Assisted Reproduction, 10. 1017/9781108867245. 008, (44-55) Struck J (2021) Ejakulationsstörungen (Ejaculatio praecox) Medikamente in der Urologie, 10. 1007/978-3-662-61492-1₁6, (287-313),. Cai Z, Song X, Zhang J, Yang B and Li H (2020) Practical Approaches to Treat ED in PDE5i NonrespondersAging and disease, 10. 14336/AD. 2019. 1028, VOL. 11, NO. 5, (1202),. Qin Z, Wang Y, Zhu J, Zhu K, Li R, Zhang L, Meng X, Xia J, Wang W, Qin C, Zhang W, Song N and Wang Z (2019) Safety and efficacy characteristics of oral drugs in patients with premature ejaculation: a Bayesian network meta-analysis of randomized controlled trialsInternational Journal of Impotence Research, 10. 1038/s41443-019-0146-7, VOL. 31, NO. 5, (356-368), Online publication date: 1-Sep-2019. Tuken M, Culha M and Serefoglu E (2019) Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction—DAP-SPEED StudyInternational Journal of Impotence Research, 10. 1038/s41443-019-0122-2, VOL. 31, NO. 2, (92-96), Online publication date: 1-Mar-2019. Jin K, Deng L, Qiu S, Tu X, Li J, Bao Y, Yang L and Wei Q (2018) Comparative efficacy and safety of phosphodiesterase-5 inhibitors with selective serotonin reuptake inhibitors in men with premature ejaculationMedicine, 10. 1097/MD. 0000000000013342, VOL. 97, NO. 49, (e13342), Online publication date: 1-Dec-2018. Sridharan K, Sivaramakrishnan G, Sequeira R and Al-Khaja K (2018) Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trialsInternational Journal of Impotence Research, 10. 1038/s41443-018-0030-x, VOL. 30, NO. 5, (215-223), Online publication date: 1-Oct-2018. Sun Y, Yang L, Bao Y, Liu Z, Liu L and Wei Q (2017) Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta-analysesWorld Journal of Urology, 10. 1007/s00345-017-2086-5, VOL. 35, NO. 12, (1817-1831), Online publication date: 1-Dec-2017. Knihavko O (2017) Results of Gel Implantation of Hyaluronic Acid under Mucous Balanus for Treatment of Early EjaculationUkraïnsʹkij žurnal medicini, bìologìï ta sportu, 10. 26693/jmbs02. 03. 065, VOL. 2, NO. 3, (65-70), Online publication date: 31-Aug-2017. Karabakan M, Keskin E, Akdemir S and Bozkurt A (2017) Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunctionInternational braz j urol, 10. 1590/s1677-5538. ibju. 2016. 0376, VOL. 43, NO. 2, (317-324), Online publication date: 1-Apr-2017. Martyn-St James M, Cooper K, Ren S, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, Frodsham L and Hood C (2017) Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysisEuropean Urology Focus, 10. 1016/j. euf. 2016. 02. 001, VOL. 3, NO. 1, (119-129), Online publication date: 1-Feb-2017. Martin C, Nolen H, Podolnick J and Wang R (2016) Current and emerging therapies in premature ejaculation: Where we are coming from, where we are goingInternational Journal of Urology, 10. 1111/iju. 13202, VOL. 24, NO. 1, (40-50), Online publication date: 1-Jan-2017. Men C, Yu L, Yuan H and Cui Y (2016) Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysisAndrologia, 10. 1111/and. 12540, VOL. 48, NO. 9, (1066-1073), Online publication date: 1-Nov-2016. Moudi E and Kasaeeyan A (2016) Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature EjaculationNephro-Urology Monthly, 10. 5812/numonthly. 32286, VOL. 8, NO. 1 Swerdloff R and Wang C (2016) Sexual Dysfunction Endocrinology: Adult and Pediatric, 10. 1016/B978-0-323-18907-1. 00123-2, (2154-2162. e3),. McMahon C (2015) Current and Emerging Treatments for Premature EjaculationSexual Medicine Reviews, 10. 1002/smrj. 49, VOL. 3, NO. 3, (183-202), Online publication date: 1-Jul-2015. Polat E, Ozbek E, Otunctemur A, Ozcan L and Simsek A (2014) Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculationAndrologia, 10. 1111/and. 12289, VOL. 47, NO. 5, (487-492), Online publication date: 1-Jun-2015. Gur S and Sikka S (2015) The characterization, current medications, and promising therapeutics targets for premature ejaculationAndrology, 10. 1111/andr. 12032, VOL. 3, NO. 3, (424-442), Online publication date: 1-May-2015. Mirone V and Fusco F (2015) Premature Ejaculation Clinical Uro-Andrology, 10. 1007/978-3-662-45018-5₇, (123-132),. Cai T, Pisano F, Magri V, Verze P, Mondaini N, D'Elia C, Malossini G, Mazzoli S, Perletti G, Gontero P, Mirone V and Bartoletti R (2014) Chlamydia trachomatis Infection Is Related to Premature Ejaculation in Chronic Prostatitis Patients: Results from a Cross‐Sectional StudyThe Journal of Sexual Medicine, 10. 1111/jsm. 12699, VOL. 11, NO. 12, (3085-3092), Online publication date: 1-Dec-2014. Althof S, McMahon C, Waldinger M, Serefoglu E, Shindel A, Ganesan Adaikan P, Becher E, Dean J, Giuliano F, Hellstrom W, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Taylor Segraves R, Sharlip I and Torres L (2014) An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE) The Journal of Sexual Medicine, 10. 1111/jsm. 12504, VOL. 11, NO. 6, (1392-1422), Online publication date: 1-Jun-2014. Althof S, McMahon C, Waldinger M, Serefoglu E, Shindel A, Adaikan P, Becher E, Dean J, Giuliano F, Hellstrom W, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Segraves R, Sharlip I and Torres L (2014) An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE) Sexual Medicine, 10. 1002/sm2. 28, VOL. 2, NO. 2, (60-90), Online publication date: 1-Jun-2014. Gajjala S and Khalidi A (2014) Premature ejaculation: A reviewIndian Journal of Sexually Transmitted Diseases and AIDS, 10. 4103/0253-7184. 142391, VOL. 35, NO. 2, (92),. Teloken P and Mulhall J (2014) Premature Ejaculation Men's Sexual Health and Fertility, 10. 1007/978-1-4939-0425-9₈, (129-144),. Lee W, Lee S, Cho S, Lee Y, Oh C, Yoo C, Cho J, Lee S and Yang D (2013) Comparison Between On‐Demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients with Lifelong Premature Ejaculation: Prospective, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter StudyThe Journal of Sexual Medicine, 10. 1111/jsm. 12287, VOL. 10, NO. 11, (2832-2841), Online publication date: 1-Nov-2013. Ciocca G, Limoncin E, Mollaioli D, Gravina G, Di Sante S, Carosa E, Lenzi A and Jannini E (2019) Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculationArab Journal of Urology, 10. 1016/j. aju. 2013. 04. 011, VOL. 11, NO. 3, (305-312), Online publication date: 1-Sep-2013. McMahon C, Jannini E, Waldinger M and Rowland D (2013) Standard Operating Procedures in the Disorders of Orgasm and EjaculationThe Journal of Sexual Medicine, 10. 1111/j. 1743-6109. 2012. 02824. x, VOL. 10, NO. 1, (204-229), Online publication date: 1-Jan-2013. Shindel A, Chen J and Sharlip I (2013) Complementary, Surgical, and Experimental Modalities for Management of Premature Ejaculation Premature Ejaculation, 10. 1007/978-88-470-2646-9₂4, (305-329),. Waldinger M (2013) Treatment of Premature Ejaculation with Selective Serotonin Re-Uptake Inhibitors Premature Ejaculation, 10. 1007/978-88-470-2646-9₁9, (229-240),. Adaikan P and Srilatha B (2013) Choice of Pharmacologic Agents Men's Health, 10. 1007/978-1-4471-4766-4₂0, (133-136),. McMahon C (2012) Management of premature ejaculationHuman Andrology, 10. 1097/01. XHA. 0000415235. 79085. e6, VOL. 2, NO. 4, (79-93), Online publication date: 1-Dec-2012. Steggall M (2012) Pharmacological management of premature ejaculationNurse Prescribing, 10. 12968/npre. 2012. 10. 11. 545, VOL. 10, NO. 11, (545-550), Online publication date: 1-Nov-2012. Asimakopoulos A, Miano R, Agrò E, Vespasiani G and Spera E (2012) Current Scientific and Clinical the of Phosphodiesterase Type 5 Inhibitors for the Treatment of Premature A Systematic Review and Journal of Sexual Medicine, VOL. 9, NO. 9, Online publication date: Giuliano F, P and (2012) for the Treatment of Premature Reviews, VOL. NO. 3, Online publication date: and T (2012) and EjaculationThe Journal of Sexual Medicine, VOL. 9, NO. 4, Online publication date: Mulhall J (2012) Premature Ejaculation Urology,. McMahon C and H Oral Agents for the Treatment of Premature Ejaculation: Review of Efficacy and Safety in the of the International Society for Sexual Medicine for Lifelong Premature EjaculationThe Journal of Sexual Medicine, VOL. 8, NO. 10, Online publication date: Jannini E, McMahon C, Chen J, A and M The of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature EjaculationThe Journal of Sexual Medicine, VOL. 8, NO. 8, Online publication date: J, Liu S, H, V, C, Yu H and C The of An VOL. NO. 2, Online publication date: T and C The Comparison of Combination and to in Men with Premature of Pharmacotherapy, VOL. NO. Online publication date: Z, Zhu Y, Yuan Y, Cui W, Jin Z, Li and Liu T Current for premature ejaculation and Journal of Andrology, VOL. NO. 4, Online publication date: A, D, R, M, Spera G and Lenzi A Is there a role for phosphodiesterase inhibitors in the treatment of premature Journal of Impotence Research, VOL. 23, NO. 1, Online publication date: Human of Medicine,. McMahon C Premature Ejaculation Practical and. A, A, F and O of ejaculation latency time and the effects of on on premature double-blind, Urology and VOL. NO. 4, Online publication date: Steggall M Premature ejaculation: assessment and clinical Journal of Urological VOL. 4, NO. 3, Online publication date: C, P, and Hellstrom in the Diagnosis and Treatment of Premature Urology VOL. 11, NO. 6, Online publication date: Althof S, C, Dean J, G, McCabe M, McMahon C, R, R, Waldinger M, Becher E, G, J, I, A, Giuliano F, Hellstrom W, Incrocci L, Jannini E, K, Parish S, H, Rowland D, Segraves R, Sharlip I, C and H International Society for Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature EjaculationThe Journal of Sexual Medicine, VOL. NO. 9, Online publication date: Lee J for the of SSRIs in Premature Ejaculation Journal of Sexual Medicine, VOL. NO. 8, Online publication date: Steggall M Premature ejaculation: assessment and in Urology, Sexual Health, VOL. NO. 3, Rowland D, McMahon C, C, Chen J, Jannini E, Waldinger M and T Disorders of Orgasm and Ejaculation in Journal of Sexual Medicine, VOL. NO. 4, Online publication date: E and Premature ejaculation: treatment Journal of AIDS, VOL. NO. 2, Online publication date: A, N, A, J, S, G, S, D, C, E and A sexual of and 50 compared with paroxetine in male An study using the of VOL. 24, NO. 1, Online publication date: J, A and R VOL. 8, NO. 1, Online publication date: A, M, D, R, Spera E, G and Spera G Effects of on ejaculatory latency time in men with premature Journal of Impotence Research, VOL. NO. 4, Online publication date: Lee H, J, Yang J, D and Lee S A of seminal in seminal in the Journal of Impotence Research, VOL. NO. 1, Online publication date: Clinical Management in G, L and Hellstrom Diagnosis and Treatment of Ejaculatory Dysfunction and Assisted Reproduction, Giuliano F and Hellstrom The treatment of premature VOL. NO. 6, Online publication date: N and B Premature ejaculation: a clinical Journal of VOL. NO. 11, Online publication date: H and R Premature Ejaculation: Current Treatment and Journal of Sexual Medicine, VOL. 5, NO. 5, Online publication date: Rowland D and McMahon C Premature Ejaculation of Sexual and Disorders, Online publication date: W, W, H and Y of Premature Journal of Urology, VOL. 49, NO. 9,. P Pharmacological treatment of premature VOL. NO. 1, Online publication date: Chen J, G, Y and H The of Phosphodiesterase Type 5 Inhibitors in the Management of Premature Ejaculation: A of and Clinical Urology, VOL. NO. 5, Online publication date: M Safety and Efficacy of in the Treatment of Premature of Clinical VOL. NO. 5, Online publication date: A, L, M and G of Phosphodiesterase Type 5 Inhibitors for Urological and Urology, VOL. NO. 4, Online publication date: Waldinger M, A, B and D The of Men with Lifelong Premature Ejaculation An Study in a Group of Journal of Sexual Medicine, VOL. 4, NO. 4, Online publication date: W, L, S and D Selective serotonin reuptake inhibitors in the treatment of premature VOL. NO. 11, Online publication date: for Premature Ejaculation Sexual M, E and Hellstrom a selective serotonin for the treatment of premature and Clinical VOL. 3, NO. 2, Online publication date: Wang W, Wang Y, S and D sildenafil primary premature A clinical Journal of Urology, VOL. NO. 4, Online publication date: Waldinger M Premature VOL. NO. 4,. K and D Phosphodiesterase Type 5 The Urology, VOL. NO. 1, Online publication date: and Sildenafil in the treatment of erectile an overview of the clinical in VOL. 1, NO. 4, Online publication date: Hellstrom and J Treatment of premature ejaculation: new drugs and treatment Urology VOL. NO. 6, Online publication date: Hellstrom and J Treatment of premature ejaculation: drugs and treatment Sexual Health VOL. 3, NO. 4, Online publication date: M A Combination Treatment for Premature Ejaculation: A Journal of Sexual Medicine, VOL. 3, NO. 6, Online publication date: Hellstrom Current and of Premature EjaculationThe Journal of Sexual Medicine, VOL. 3, Online publication date: Sharlip I Guidelines for the Diagnosis and Management of Premature EjaculationThe Journal of Sexual Medicine, VOL. 3, Online publication date: Segraves R ejaculation: a review of prevalence and Journal of Impotence Research, VOL. NO. Online publication date: Jannini E, Carosa E, M, F and Lenzi A Update on of Premature Ejaculation: The for Pharmacological Update VOL. 4, NO. 4, Online publication date: I, R, C, A and A (2018) Sildenafil in of Urology, VOL. NO. 6, Online publication date: Waldinger M Emerging drugs for premature ejaculationExpert Opinion on Emerging VOL. 11, NO. 1, Online publication date: N, M, M, D, D and S (2013) and of Dapoxetine a for the Treatment of Premature EjaculationThe Journal of Clinical VOL. NO. 3, Online publication date: Althof S (2018) and of Premature of Urology, VOL. NO. 3, Online publication date: clinical in lower sexual Journal of VOL. NO. Online publication date: A, M, A, M, K and Comparison of efficacy of sildenafil plus and in treatment of premature VOL. NO. 2, Online publication date: M, D, S, A and N a treatment for premature not with phosphodiesterase-5 Journal of Impotence Research, VOL. NO. 1, Online publication date: Mulhall J Current and pharmacotherapeutic in treatment of premature VOL. NO. 1, Online publication date: McMahon C Ejaculatory Disorders Sexual R and G Oral for Erectile Dysfunction Sexual. Abdel-Hamid I a for the treatment of VOL. 10, NO. Online publication date: McMahon C The and management of premature Clinical Urology, VOL. 2, NO. 9, Online publication date: G, H and I and a update of Journal of Clinical VOL. NO. 6, McMahon C, M, K, N, S and M Efficacy of Sildenafil in Men with Premature EjaculationThe Journal of Sexual Medicine, VOL. 2, NO. 3, Online publication date: R, S, M, A, L, A, F, Mondaini N, G, S, F, G and M and of phosphodiesterase type 5 in human and of VOL. 11, NO. 2, Online publication date: M and Hellstrom for Ejaculatory Disorders and Erectile Dysfunction in the Andrology, D Sexual dysfunction associated with Opinion on VOL. 3, NO. 5, Online publication date: Waldinger M, A, D and B of for the of efficacy of drug treatment of premature ejaculation: a systematic review and Journal of Impotence Research, VOL. NO. 4, Online publication date: McMahon C, C, Incrocci L, M, Rowland D, Waldinger M and Z Disorders of Orgasm and Ejaculation in Journal of Sexual Medicine, VOL. 1, NO. 1, Online publication date: D, J, G, R, J, T, A and I (2018) of Urology, VOL. NO. 1, Online publication date: Waldinger M Lifelong premature ejaculation: from to VOL. NO. 2, Online publication date: McMahon C Ejaculatory Dysfunction and Sexual. Waldinger M Premature Ejaculation: and Treatment to and Sexual. P Serotonin in the and and of. J, and M (2016) Erectile International Journal of in Medicine, VOL. NO. 3, Online publication date: Mondaini N, R, G, F, Di F, G and M Sildenafil not sexual function in men without erectile dysfunction but the Journal of Impotence Research, VOL. NO. 3, Online publication date: 2002 by American Urological Association, ANDREA SALONIA by this TOMMASO MAGA by this RENZO COLOMBO by this VINCENZO SCATTONI by this ALBERTO BRIGANTI by this ANDREA CESTARI by this GIORGIO GUAZZONI by this PATRIZIO RIGATTI by this FRANCESCO MONTORSI by this All